Guillain–Barré Syndrome von Yuki, Nobuhiro, Hartung, Hans-Peter

Volltext

Role of B Cells in Multiple Sclerosis and Related Disorders von Comi, Giancarlo, Bar‐Or, Amit, Lassmann, Hans, Uccelli, Antonio, Hartung, Hans‐Peter, Montalban, Xavier, Sørensen, Per Solberg, Hohlfeld, Reinhard, Hauser, Stephen L.

Volltext

COVID-19 and management of neuroimmunological disorders von Hartung, Hans-Peter, Aktas, Orhan

Volltext

Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis von Chun, Jerold, Hartung, Hans-Peter

Volltext

Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision‐Making von Hartung, Hans‐Peter

Volltext

Correction to “Hartung H‐P. Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision‐Making.” von Hartung, Hans‐Peter

Volltext

Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke von Gliem, Michael, Krammes, Kristina, Liaw, Lucy, van Rooijen, Nico, Hartung, Hans-Peter, Jander, Sebastian

Volltext

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies von Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin, Joshi, Manher A.

Volltext

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial von Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Ding, Ning, Cohen, Jeffrey A

Volltext

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial von Cohen, Jeffrey A, Comi, Giancarlo, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Huang, Vivian, Kappos, Ludwig

Volltext

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised,... von Wolinsky, Jerry S, Arnold, Douglas L, Brochet, Bruno, Hartung, Hans-Peter, Montalban, Xavier, Naismith, Robert T, Manfrini, Marianna, Overell, James, Koendgen, Harold, Sauter, Annette, Bennett, Iain, Hubeaux, Stanislas, Kappos, Ludwig, Hauser, Stephen L

Volltext

Thinking outside the box: non-canonical targets in multiple sclerosis von Bierhansl, Laura, Hartung, Hans-Peter, Aktas, Orhan, Ruck, Tobias, Roden, Michael, Meuth, Sven G.

Volltext

Macrophages prevent hemorrhagic infarct transformation in murine stroke models von Gliem, Michael, Mausberg, Anne Kathrin, Lee, John-Ih, Simiantonakis, Ioannis, van Rooijen, Nico, Hartung, Hans-Peter, Jander, Sebastian

Volltext

Prognostic relevance of the C‐X‐C motif chemokine ligand 13 and interleukin‐8 in predicting the transition from clinically isolated syndrome to multiple sclerosis von Klíčová, Kateřina, Mareš, Jan, Sobek, Ondřej, Rous, Zuzana, Rous, Matouš, Raška, Milan, Hartung, Hans‐Peter

Volltext

CSI: Multiple sclerosis. Tracing optic nerve involvement by standardized optical coherence tomography von Aktas, Orhan, Hartung, Hans‐Peter

Volltext

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Wolinsky, Jerry S, Arnold, Douglas L, Klingelschmitt, Gaelle, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Chin, Peter, Mairon, Nicole, Garren, Hideki, Kappos, Ludwig

Volltext

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis von Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

Volltext

The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history von Sorensen, Per Soelberg, Sellebjerg, Finn, Hartung, Hans-Peter, Montalban, Xavier, Comi, Giancarlo, Tintoré, Mar

Volltext

Coproduction of healthcare service von Batalden, Maren, Batalden, Paul, Margolis, Peter, Seid, Michael, Armstrong, Gail, Opipari-Arrigan, Lisa, Hartung, Hans

Volltext

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis von Steinman, Lawrence, Fox, Edward, Hartung, Hans-Peter, Alvarez, Enrique, Qian, Peiqing, Wray, Sibyl, Robertson, Derrick, Huang, DeRen, Selmaj, Krzysztof, Wynn, Daniel, Cutter, Gary, Mok, Koby, Hsu, Yanzhi, Xu, Yihuan, Weiss, Michael S., Bosco, Jenna A., Power, Sean A., Lee, Lily, Miskin, Hari P., Cree, Bruce A.C.

Volltext